Stephen A. Douglas

6.9k total citations
121 papers, 4.9k citations indexed

About

Stephen A. Douglas is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Stephen A. Douglas has authored 121 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Surgery, 48 papers in Cardiology and Cardiovascular Medicine and 46 papers in Pharmacology. Recurrent topics in Stephen A. Douglas's work include Cardiovascular, Neuropeptides, and Oxidative Stress Research (52 papers), Apelin-related biomedical research (45 papers) and Nitric Oxide and Endothelin Effects (33 papers). Stephen A. Douglas is often cited by papers focused on Cardiovascular, Neuropeptides, and Oxidative Stress Research (52 papers), Apelin-related biomedical research (45 papers) and Nitric Oxide and Endothelin Effects (33 papers). Stephen A. Douglas collaborates with scholars based in United States, United Kingdom and Canada. Stephen A. Douglas's co-authors include Eliot H. Ohlstein, Adel Giaid, C. Robin Hiley, Douglas G. Johns, Nambi Aiyar, David J. Behm, Zhaohui Ao, Robert N. Willette, Dashyant Dhanak and John D. Elliott and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Circulation Research.

In The Last Decade

Stephen A. Douglas

118 papers receiving 4.7k citations

Peers

Countries citing papers authored by Stephen A. Douglas

Since Specialization

Citations

This map shows the geographic impact of Stephen A. Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Douglas more than expected).

Fields of papers citing papers by Stephen A. Douglas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen A. Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Douglas. The network helps show where Stephen A. Douglas may publish in the future.

Co-authorship network of co-authors of Stephen A. Douglas

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen A. Douglas. A scholar is included among the top collaborators of Stephen A. Douglas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen A. Douglas. Stephen A. Douglas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	POS0280 EARLY EXPERIENCE WITH JAK INHIBITORS IN JIA IN ROUTINE CLINICAL PRACTICE 2023 ·Annals of the Rheumatic Diseases ·Lianne Kearsley‐Fleet, (unknown), Michael W. Beresford, Stephen A. Douglas, Helen Foster, T. R. E. Southwood, Kimme L Hyrich	1
2	Food for Thought: Screening Families for Food Insecurity Prior to Discussing Discontinuation of Artificial Nutrition/Hydration at End-of-Life (CS327) 2023 ·Journal of Pain and Symptom Management ·(unknown), Stephen A. Douglas, (unknown), (unknown), (unknown)	0
3	Urotensin II evokes neurotransmitter release from rat cerebrocortical slices 2008 ·Neuroscience Letters ·Tomoko Ono, Yoko Kawaguchi, Mihoko Kudo, Tetsuya Kushikata, Eiji Hashiba, Hitoshi Yoshida, Tsuyoshi Kudo, Ken‐Ichi Furukawa, Stephen A. Douglas, Remo Guerrini, Girolamo Calò, Kazuyoshi Hirota	14
4	The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects 2007 ·British Journal of Pharmacology ·David G. Johns, David J. Behm, Deborah J. Walker, Ao Zhang, (unknown), Dion A. Daniels, (unknown), Simon J. Dowell, (unknown), Paul G. Green, Usman Shabon, Weike Bao, N Aiyar, (unknown), Andrew J. Brown, Alastair Morrison, Stephen A. Douglas	198
5	Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor 2007 ·Biochemical and Biophysical Research Communications ·Douglas G. Johns, Zhaohui Ao, (unknown), (unknown), (unknown), (unknown), Nabil A. Elshourbagy, Quinn Lu, Nambi Aiyar, Stephen A. Douglas	35
6	Urotensin II and renal function in the rat 2006 ·Kidney International ·Wei Song, (unknown), Weiqun Lu, Ao Zhang, Douglas G. Johns, Stephen A. Douglas, R. J. Balment, Nick Ashton	56
7	The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systems 2006 ·British Journal of Pharmacology ·David J. Behm, Gerald P. Stankus, Christopher Doe, Robert N. Willette, Henry M. Sarau, James J. Foley, Dulcie B. Schmidt, Parvathi Nuthulaganti, James A. Fornwald, Robert S. Ames, David G. Lambert, Girolamo Calò, Valeria Camarda, Nambi Aiyar, Stephen A. Douglas	32
8	Rosiglitazone Protects against Ischemia/Reperfusion-Induced Leukocyte Adhesion in the Zucker Diabetic Fatty Rat 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Douglas G. Johns, Zhaohui Ao, Marianne Eybye, Alan R. Olzinski, Melissa H. Costell, (unknown), Stephen A. Smith, Stephen A. Douglas, Colin H. Macphee	19
9	Identification and pharmacological characterization of native, functional human urotensin‐II receptors in rhabdomyosarcoma cell lines 2004 ·British Journal of Pharmacology ·Stephen A. Douglas, Diane P. Naselsky, Zhaohui Ao, Jyoti Disa, Christopher L. Herold, (unknown), Nambi Aiyar	32
10	Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors 2004 ·European Journal of Pharmacology ·David J. Behm, Christopher L. Herold, Valeria Camarda, Nambi Aiyar, Stephen A. Douglas	20
11	Production and Characterization of Monoclonal Antibodies against the Vasoconstrictive Peptide Human Urotensin-II 2003 ·PubMed ·Jui‐Lan Su, Zhaohui Ao, Nambi Aiyar, Byron Ellis, John D. Martin, Stephen A. Douglas, Frederick C. Kull	5
12	p38 MAPK Inhibitors Ameliorate Target Organ Damage in Hypertension: Part 1. p38 MAPK-Dependent Endothelial Dysfunction and Hypertension 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Haisong Ju, David J. Behm, (unknown), Marianne Eybye, (unknown), Alan R. Olzinski, Stephen A. Douglas, Robert N. Willette	54
13	Molecular cloning and pharmacological characterization of bovine calcitonin receptor-like receptor from bovine aortic endothelial cells 2002 ·Biochemical Pharmacology ·Nambi Aiyar, Jyoti Disa, Zhaohui Ao, Dong Xu, (unknown), Kodandaram Pillarisetti, Narayanan Parameswaran, Shalley K. Gupta, Stephen A. Douglas, Ponnal Nambi	15
14	Human urotensin‐II is a potent spasmogen of primate airway smooth muscle 2000 ·British Journal of Pharmacology ·Douglas W.P. Hay, Mark A. Luttmann, Stephen A. Douglas	26
15	Human Urotensin-II is a Potent Vasoactive Peptide 2000 ·Journal of Cardiovascular Pharmacology ·Stephen A. Douglas, (unknown), Charles F. Sauermelch, Robert W. Coatney, (unknown), (unknown), Eliot H. Ohlstein, Nambi Aiyar, (unknown)	42
16	Endothelin receptor subtypes in the pathogenesis of angioplasty-induced neointima formation in the rat: a comparison of selective ETA receptor antagonism and dual ETA/ETB receptor antagonism using BQ-123 and SB 209670. 1995 ·PubMed ·Stephen A. Douglas, Lynne M. Vickery‐Clark, Calvert Louden, J. D. ELLIOTT, (unknown)	13
17	The complete Lincoln-Douglas debates of 1858 1991 ·University of Chicago Press eBooks ·Abraham Lincoln, Stephen A. Douglas, (unknown)	18
18	Endothelial modulation and changes in endothelin pressor activity during hypoxia in the rat isolated perfused superior mesenteric arterial bed 1991 ·British Journal of Pharmacology ·Stephen A. Douglas, (unknown), C. Robin Hiley	14
19	Endothelium‐dependent vascular activities of endothelin‐like peptides in the isolated superior mesenteric arterial bed of the rat 1990 ·British Journal of Pharmacology ·Stephen A. Douglas, C. Robin Hiley	50
20	Blood, believer, and brother : the development of voluntary associations in Malaysia 1973 ·Stephen A. Douglas, Paul Pedersen	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact